Symptoms and health
GLP-1, surgery, pregnancy and other medicines: plan the conversation
Tell the relevant healthcare team about your exact GLP-1 product before a procedure, pregnancy planning or a new prescription. Instructions differ by medicine and situation; do not copy a universal pause schedule.
Before anesthesia or sedation
The American Society of Anesthesiologists explains that GLP-1 medicines can leave food in the stomach longer, which matters during anesthesia or deep sedation. Current guidance allows many patients to continue treatment, but the care team makes a plan based on individual risk. “Everyone must stop for one week” is not a reliable universal rule.
Contact the procedural team in advance. Tell them the product, presentation, prescribed schedule, last actual administration and any nausea, vomiting or fullness. Request written instructions for the procedure and afterward, including whom to call if plans change. In an emergency, tell the treating team immediately; do not delay needed care to calculate a medication-free interval.
Pregnancy planning deserves an early discussion
The MHRA pregnancy and contraception guidance advises against GLP-1 use during pregnancy and describes product-specific planning before trying to conceive. If pregnancy is possible or confirmed, contact your prescriber promptly for individualized instructions, including how the underlying condition will be managed. This page does not calculate a safe conception date.
Tirzepatide has a specific interaction with oral hormonal contraception. Its US prescribing information calls for a non-oral method or added barrier contraception for four weeks after starting and after each dose increase. Ask a clinician or pharmacist to explain what applies to your product and method. Vomiting or diarrhea can also make contraceptive questions time-sensitive.
Bring the whole medicine list
The Wegovy label describes delayed gastric emptying and potential effects on oral medicines. Make the review about actual products rather than the broad question “Can I take other pills?” Include prescriptions, over-the-counter products, supplements and contraceptives. Do not discontinue another prescription because a website flags a possible interaction.
- Product identity: exact brand, ingredient, presentation and the instructions you were given. Keep dose and unit as prescribed; do not convert pen clicks or syringe markings.
- Dates: last actual administration, procedure or consultation date, and when any new medicine started. Mark approximate information honestly.
- Relevant symptoms: what happened, when it started and whether it is continuing. A short description can be enough to begin the call.
- Agreed plan: who gave instructions, the date, what remains unclear and a contact number for follow-up. Ask which team is responsible if advice seems to conflict.
The free appointment preparation tool can help organize these questions. Keep procedure instructions from the hospital separate from an app reminder.
Frequently asked questions
Should I automatically skip the dose before surgery?
No universal schedule fits every case. Ask your prescriber and procedural team for instructions specific to your medicine and procedure.
Can Capydose decide when pregnancy is safe?
No. A dose timeline does not calculate fetal exposure or a safe conception date. Discuss plans with the professionals providing your care.
Is a reminder the same as medical clearance?
No. A reminder only reflects a schedule. A clinician must confirm any preparation, treatment change or follow-up plan.
A record you can bring to your appointment
An accurate administration history can help you answer the practical question “When did you last take it?” without guessing. Capydose keeps dose, symptom and wellbeing entries together, with PDF or CSV exports you choose to share. Its capybara is a friendly visual companion for your routine. It does not detect complications or provide live medical care.
Explore Capydose for iPhone or start with the free wellbeing journal. In-app tracking requires Premium after onboarding and iOS 18 or later. Android remains in review.